Prognostic Significance of the Number of Lymph Node Metastases in Esophageal Cancer

Journal of the American College of Surgeons

Volumn 206, Issue 2, 2008, Pages 239-246

  Greenstein, Alexander J ^a   Litle, Virginia R ^a   Swanson, Scott J ^a   Divino, Celia M ^a   Packer, Stuart ^a   Wisnivesky, Juan P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; GENDER; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RACE;

AGED; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 38349154902     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2007.09.003     Document Type: Article

References (31)

1. Siewert J.R., Holscher A.H., and Dittler H.J. Preoperative staging and risk analysis in esophageal carcinoma. Hepatogastroenterology 37 (1990) 382-387
2. Killinger Jr. W.A., Rice T.W., Adelstein D.J., et al. Stage II esophageal carcinoma: The significance of T and N. J Thorac Cardiovasc Surg 111 (1996) 935-940
3. Ellis Jr. F.H., Watkins Jr. E., Krasna M.J., et al. Staging of carcinoma of the esophagus and cardia: A comparison of different staging criteria. J Surg Oncol 52 (1993) 231-235
4. Rice T.W., Blackstone E.H., Rybicki L.A., et al. Refining esophageal cancer staging. J Thorac Cardiovasc Surg 125 (2003) 1103-1113
5. Korst R.J., Rusch V.W., Venkatraman E., et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 115 (1998) 660-669 discussion 669-670
6. Rizk N., Venkatraman E., Park B., et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 132 (2006) 1374-1381
7. Bollschweiler E., Baldus S.E., Schroder W., et al. Staging of esophageal carcinoma: Length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?. J Surg Oncol 94 (2006) 355-363
8. Lee H.Y., Choi H.J., Park K.J., et al. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol 26 (2007)
9. Vinh-Hung V., Verschraegen C., Promish D.I., et al. Ratios of involved nodes in early breast cancer. Breast Cancer Res 6 (2004) R680-R688
10. Voordeckers M., Vinh-Hung V., Van de Steene J., et al. The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol 70 (2004) 225-230
11. Sant M., Allemani C., Capocaccia R., et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106 (2003) 416-422
12. Nitti D., Marchet A., Olivieri M., et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: Analysis of a large European monoinstitutional experience. Ann Surg Oncol 10 (2003) 1077-1085
13. Herr H.W. Superiority of ratio based lymph node staging for bladder cancer. J Urol 169 (2003) 943-945
14. Berger A.C., Sigurdson E.R., LeVoyer T., et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23 (2005) 8706-8712
15. Berger A.C., Watson J.C., Ross E.A., and Hoffman J.P. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70 (2004) 235-240 discussion 240
16. Eloubeidi M.A., Desmond R., Arguedas M.R., et al. Prognostic factors for the survival of patients with esophageal carcinoma in the US: The importance of tumor length and lymph node status. Cancer 95 (2002) 1434-1443
17. Kunisaki C., Akiyama H., Nomura M., et al. Developing an appropriate staging system for esophageal carcinoma. J Am Coll Surg 201 (2005) 884-890
18. van Sandick J.W., van Lanschot J.J., ten Kate F.J., et al. Indicators of prognosis after transhiatal esophageal resection without thoracotomy for cancer. J Am Coll Surg 194 (2002) 28-36
19. Portale G., Hagen J.A., Peters J.H., et al. Modern 5-year survival of resectable esophageal adenocarcinoma: Single institution experience with 263 patients. J Am Coll Surg 202 (2006) 588-596 discussion 596-598
20. Surveillance, Epidemiology, and End Results (SEER) program public-use data (1973-2000) (2006), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, Washington, DC
21. SEER cancer statistics review, 1975-2003 (2006), National Cancer Institute, Bethesda, MD
22. AJCC cancer staging. 6th ed. (2002), Springer-Verlag, New York
23. Kunisaki C., Akiyama H., Nomura M., et al. Developing an appropriate staging system for esophageal carcinoma. J Am Coll Surg 201 (2005) 884-890
24. Kaplan E.L., and Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 53 (1958) 457-481
25. Ellis Jr. F.H., Heatley G.J., and Balogh K. Proposal for improved staging criteria for carcinoma of the esophagus and cardia. Eur J Cardiothorac Surg 12 (1997) 361-364 discussion 364-365
26. Rodriguez Santiago J.M., Munoz E., Marti M., et al. Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol 31 (2005) 59-66
27. Warren J.L., Klabunde C.N., Schrag D., et al. Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40 (2002) IV,3-18
28. Cooper G.S., Virnig B., Klabunde C.N., et al. Use of SEER-Medicare data for measuring cancer surgery. Med Care 40 (2002) IV,43-48
29. Smith Sehdev A.E., and Hutchins G.M. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med 161 (2001) 277-284
30. Kircher T., Nelson J., and Burdo H. The autopsy as a measure of accuracy of the death certificate. N Engl J Med 313 (1985) 1263-1269
31. Weinstock M.A., Bogaars H.A., Ashley M., et al. Inaccuracies in certification of nonmelanoma skin cancer deaths. Am J Public Health 82 (1992) 278-281